(Q38495675)

English

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

scientific article published on September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. (English)

1 reference

Europe PubMed Central

3 September 2017

anti-retroviral agent

0 references

Mycobacterium tuberculosis

0 references

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

1

object named as

Kirk O

1 reference

Europe PubMed Central

3 September 2017

3

object named as

Mocroft A

1 reference

Europe PubMed Central

3 September 2017

author name string

Gatell JM

2

1 reference

Europe PubMed Central

3 September 2017

Pedersen C

4

1 reference

Europe PubMed Central

3 September 2017

Proenca R

5

1 reference

Europe PubMed Central

3 September 2017

Brettle RP

6

1 reference

Europe PubMed Central

3 September 2017

Barton SE

7

1 reference

Europe PubMed Central

3 September 2017

Sudre P

8

1 reference

Europe PubMed Central

3 September 2017

Phillips AN

9

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

3 September 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

3 September 2017

162

1 reference

Europe PubMed Central

3 September 2017

3 Pt 1

1 reference

Europe PubMed Central

3 September 2017

865-872

1 reference

Europe PubMed Central

3 September 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Natural history of HIV infection in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: increasing incidence, unchanged prognosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Changes in use of antiretroviral therapy in regions of Europe over time

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.3.9908018

21 January 2018

Identifiers

10.1164/AJRCCM.162.3.9908018

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38495675&oldid=1796564876"